Research in Social & Administrative Pharmacy最新文献

{"title":"Patterns of direct oral anticoagulant adherence after cardiovascular or bleeding events among older adults with Atrial Fibrillation","authors":"B. Fatima, A. Mohan, S. Abughosh","doi":"10.1016/j.sapharm.2023.12.017","DOIUrl":"https://doi.org/10.1016/j.sapharm.2023.12.017","url":null,"abstract":"","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"20 4","pages":"Pages e99-e100"},"PeriodicalIF":3.9,"publicationDate":"2024-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140051941","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Androgen Deprivation Therapy and the Risk of Rheumatic Autoimmune Diseases in Older Men with Prostate Cancer","authors":"M. Albayyaa , B. Digbeu , J. Baillargeon","doi":"10.1016/j.sapharm.2023.12.014","DOIUrl":"https://doi.org/10.1016/j.sapharm.2023.12.014","url":null,"abstract":"","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"20 4","pages":"Pages e98-e99"},"PeriodicalIF":3.9,"publicationDate":"2024-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140052210","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pharmacists’ perspectives and perceived barriers to counselling patients with kidney stones","authors":"Huda Y. Almomani ,&nbsp;Ensaf Y. Almomani ,&nbsp;Ahmad Qablan ,&nbsp;Abass Al-Momany","doi":"10.1016/j.sapharm.2024.02.018","DOIUrl":"10.1016/j.sapharm.2024.02.018","url":null,"abstract":"<div><h3>Background</h3><p>The global increase in kidney stone incidence and its complications emphasise the need for effective management. While pharmacists can play a significant role in counselling and guiding patients, their practices in managing patients with kidney stones remain unclear.</p></div><div><h3>Objective(s)</h3><p>To explore counselling practices and experiences of pharmacists when dealing with patients with kidney stones and to identify the barriers they face while providing counselling.</p></div><div><h3>Methods</h3><p>A qualitative study was performed using semi-structured phone interviews with pharmacists practising in Jordan. Pharmacists were selected using quota sampling from those who took part in a previous study focused on pharmacists’ knowledge of kidney stone aetiology and treatment. The COM-B Model of Behaviour Change was used to develop the interview guide and the analytical framework. Interviews were transcribed verbatim and analysed using a deductive thematic approach based on the pre-specified analytical framework.</p></div><div><h3>Results</h3><p>Seven pharmacists (85.7% female; 57.1% working in community pharmacies) were interviewed. Counselling practices of patients with kidney stones were categorised into five themes: (1) Pharmacists’ beliefs about patient counselling: perceived importance and desire to improve health through counselling; (2) Most priority patients: Types of patients mostly counselled; (3) Content of kidney stones-specific counselling: patient assessment and recommendations about kidney stones management; (4) Duration of the counselling sessions: time offered and influencing factors; (5) Barriers to patient counselling: patient-related, and pharmacist- and doctor-related challenges.</p></div><div><h3>Conclusions</h3><p>Pharmacists recognise the crucial role of kidney stones counselling but face gaps in their practices, including incomplete dietary education, limited knowledge of medication prescriptions, inconsistent patient-specific approaches, and potential communication challenges. These gaps can be overcome by enhancing training, standardising protocols of kidney stone treatment, promoting interprofessional communication, and improving communication strategies. Future research, including quantitative assessments, is needed to inform strategies that optimise patient counselling practices and facilitate improved outcomes.</p></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"20 6","pages":"Pages 123-133"},"PeriodicalIF":3.9,"publicationDate":"2024-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140087650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A systematic review of synchronous telepharmacy service models for adult outpatients with cancer","authors":"Marissa Ryan ,&nbsp;Tara Poke ,&nbsp;Elizabeth C. Ward ,&nbsp;Christine Carrington ,&nbsp;Centaine L. Snoswell","doi":"10.1016/j.sapharm.2024.02.016","DOIUrl":"10.1016/j.sapharm.2024.02.016","url":null,"abstract":"<div><h3>Background</h3><p>Telephone and videoconsults are known synchronous telepharmacy modalities being used to respond to the demand for outpatient pharmacy services. However, little is known about the evidence for cancer telepharmacy service models.</p></div><div><h3>Objectives</h3><p>To review existing evidence regarding synchronous telepharmacy service models for adult outpatients with cancer, with a secondary focus on outcomes, enablers, and barriers.</p></div><div><h3>Methods</h3><p>A PROSPERO registered systematic review was conducted using PubMed, CINAHL, and EMBASE in March 2023. Key search terms included pharmacy, telepharmacy, and outpatient. During article selection in Covidence, an extra inclusion criterion of synchronous cancer-focused services was applied; data extraction and narrative analysis were then performed.</p></div><div><h3>Results</h3><p>From 2129 non-duplicate articles, 8 were eligible for inclusion, describing 7 unique patient populations. The service models included pre-treatment medication history taking, adherence monitoring, toxicity assessment, and discharge follow-up. Studies found synchronous telepharmacy services can improve timeliness of care, optimise workload management, and provide individualised and convenient efficacy monitoring and counselling. One study of 177 patients on immune checkpoint inhibitors found 38% of the 726 telephone consults involved at least one intervention. When videoconsults were compared directly with telephone consults for pre-treatment medication history, it was found scheduled videoconsults had a significantly higher success rate than unscheduled telephone consults, and that videoconsults also represented increased funding and equivalent time efficiency. When telephone follow-up was compared to no follow-up, improved treatment adherence was seen, and progression-free survival was significantly higher for the telephone group (6.1 months vs 3.7 months, p = 0.001). Reported enablers included physician buy-in, staff resources, and correct utilisation of technology, while identified barriers included time investment required and technical issues.</p></div><div><h3>Conclusion</h3><p>Both telephone and videoconsult modalities are being used to deliver synchronous telepharmacy services across a range of outpatient services. Although more evidence is needed, data to date supports positive service benefits and enhanced care.</p></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"20 6","pages":"Pages 25-33"},"PeriodicalIF":3.9,"publicationDate":"2024-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1551741124000810/pdfft?md5=699f83be768c0716801a5a52c357e3e6&pid=1-s2.0-S1551741124000810-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140089722","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Exploring the implementation of a novel community pharmacist-led support service for people living with severe and persistent mental illness","authors":"Ricki Ng ,&nbsp;Sarira El-Den ,&nbsp;Jack C. Collins ,&nbsp;Victoria Stewart ,&nbsp;Sara S. McMillan ,&nbsp;Jie Hu ,&nbsp;Amanda J. Wheeler ,&nbsp;Claire L. O'Reilly","doi":"10.1016/j.sapharm.2024.02.017","DOIUrl":"10.1016/j.sapharm.2024.02.017","url":null,"abstract":"<div><h3>Background</h3><p>Community pharmacists are well-placed to promote and provide mental health medication management services. However, literature evaluating the impact of pharmacy services in supporting people living with severe and persistent mental illness (SPMI) is currently limited. An individualised, goal-oriented pharmacist-led support service that focused on improving the physical and mental health of consumers living with SPMI, namely the <em>PharMIbridge</em> intervention, was provided to consumer participants as part of the <em>PharMIbridge</em> Randomised Controlled Trial (RCT).</p></div><div><h3>Objective(s)</h3><p>To explore the experiences of the participants who delivered and supported the implementation of the <em>PharMIbridge</em> intervention and propose ideas and supports needed for broader implementation and sustainability of pharmacist-led support services for people living with SPMI.</p></div><div><h3>Methods</h3><p>Interviews and focus group discussions were undertaken with <em>PharMIbridge</em> pharmacists and mentors, respectively. Audio-recordings were de-identified and transcribed verbatim. Data analysis was conducted using an iterative, inductive approach. The key themes identified were furthered divided into subthemes. Subthemes were then mapped to the EPIS (Exploration, Preparation, Implementation and Sustainment) framework.</p></div><div><h3>Results</h3><p>Data were collected from one focus group involving six RCT mentors and 16 semi-structured interviews with community pharmacists. Five overarching themes emerged: “Training needs”, “Pharmacist integration within the healthcare system”, “Environmental factors”, “Attitudes and behaviour” and “Pharmacy operations”. Twelve subthemes were mapped to EPIS phases “Preparation”, “Implementation” and “Sustainment” and EPIS constructs “Outer” context, “Inner” context and “Bridging” factors.</p></div><div><h3>Conclusion</h3><p>Adequate remuneration and supports to encourage healthcare professional collaboration are necessary to establish and sustain functioning, integrated pharmacy mental health services. A shift in pharmacy business and workflow models is necessary to support community pharmacies to implement mental health services. In addition, there is a need to promote psychological support services to ensure that pharmacists are well supported while delivering pharmacy mental health services.</p></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"20 6","pages":"Pages 113-122"},"PeriodicalIF":3.9,"publicationDate":"2024-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1551741124000822/pdfft?md5=ccb3cf0306a9ff4d3705e44c74a3f059&pid=1-s2.0-S1551741124000822-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140087125","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Could pharmacy technicians play a role in supporting the appropriate and safe use of traditional and complementary medicines?","authors":"Shane P. Desselle ,&nbsp;Carolina Oi Lam Ung ,&nbsp;Joanna E. Harnett","doi":"10.1016/j.sapharm.2024.02.019","DOIUrl":"10.1016/j.sapharm.2024.02.019","url":null,"abstract":"<div><p>Across the world traditional and complementary medicine (T&amp;CM) product use is prevalent with some countries reporting greater than 50% of the population using these products. T&amp;CM products are primarily self-selected through retail outlets including pharmacies. Pharmacists across the world generally agree they should play a role in ensuring the appropriate and safe use of T&amp;CM products but report being time and resource poor to do so. In this commentary, it is proposed that pharmacy technicians as members of the pharmacy workforce, who with adequate education, and supportive technologies could support pharmacists in providing guidance to consumers and patients about the appropriate and safe use of T&amp;CM products. Pharmacy technicians play a crucial role in the pharmacy workforce, serving as integral members of healthcare teams fulfilling a wide array of tasks essential for the efficient functioning of pharmacies and ensuring the safe dispensation of medications. They have been described by pharmacists as the “the face of the pharmacy” in the community setting and relied on not only for mitigating and triaging problems, but also be primarily responsible for developing rapport, eliciting trust and even loyalty from pharmacy patrons. As such, there is a momentous opportunity for pharmacy technicians to play a role in providing T&amp;CM advice and triaging the need for pharmacists’ intervention where harm, or risk of is identified.</p></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"20 6","pages":"Pages 170-173"},"PeriodicalIF":3.9,"publicationDate":"2024-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140186034","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The information seeking behaviors of caregivers in the management of childhood fever – A systematic literature review","authors":"Daniel Arias,&nbsp;Esther So,&nbsp;Timothy F. Chen,&nbsp;Rebekah J. Moles","doi":"10.1016/j.sapharm.2024.02.015","DOIUrl":"10.1016/j.sapharm.2024.02.015","url":null,"abstract":"<div><h3>Introduction</h3><p>Parents' and caregivers' non-evidence-based childhood fever management ‘fever phobic’ practices have remained relatively stable over more than 34 years despite successful educational interventions. This systematic review aimed to assess the information seeking behavior of caregivers managing fever in their children, as well as to compile the fever management practices undertaken by caregivers by investigating underlying factors influencing them.</p></div><div><h3>Methods</h3><p>The electronic databases Pubmed, CINAHL, Medline, and International Pharmaceutical Abstracts were searched using key terms including, fever, child, caregiver, and management. Studies were included if they were written in English, published between January 1980 and January 2021, explored generalized childhood fever management practices of caregivers, and factors which influence fever management. Data extracted included study year and design, location, dimensions of fever management explored (i.e., knowledge, beliefs, detection, and/or treatment of fever), factors influencing management, and information sources used by caregivers.</p></div><div><h3>Results</h3><p>In total, 36 studies were eligible for inclusion in the study. Twenty-nine of the studies were designed as a cross-sectional survey, six studies were interviews and the remainder were pre-post studies. The review of studies found that parents and caregivers sourced childhood fever management information most commonly from friends and family or their own personal experiences, however, participants most commonly sourced doctors/general practitioners as their first line of information when required. Over the years, trends showed that doctors as well as the internet were more frequently being used as a first line source of information by caregivers.</p></div><div><h3>Conclusions</h3><p>Despite decades of research, education and development of evidence-based guidelines caregivers continue to exhibit ‘fever phobia’ when caring for febrile children. This is demonstrated by their continued use of non-evidence-based methods and increasing reliance on, and incorrect use of antipyretics, alternating antipyretics if fever is not sufficiently reduced or returns. There is an increasing need for the development of easy to access digital resources for caregiver as internet use is rising which mirrors best practice taught to professionals.</p></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"20 7","pages":"Pages 559-575"},"PeriodicalIF":3.9,"publicationDate":"2024-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140466643","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Developing indicators for medication-related readmissions based on a Delphi consensus study","authors":"Nicole Schönenberger ,&nbsp;Anne-Laure Blanc ,&nbsp;Balthasar L. Hug ,&nbsp;Manuel Haschke ,&nbsp;Aljoscha N. Goetschi ,&nbsp;Ursina Wernli ,&nbsp;Carla Meyer-Massetti","doi":"10.1016/j.sapharm.2024.02.012","DOIUrl":"10.1016/j.sapharm.2024.02.012","url":null,"abstract":"<div><h3>Background</h3><p>Medication-related readmissions challenge healthcare systems by burdening patients, increasing costs and straining resources. However, to date, there has been no consensus study on indicators for medication-related readmissions.</p></div><div><h3>Objectives</h3><p>This Delphi study aimed to develop a consensus-based set of indicators for detecting patients at risk of medication-related readmission.</p></div><div><h3>Methods</h3><p>An expert panel of clinical pharmacists, physicians and nursing experts participated in a two-round Delphi study. In round 1, 31 indicators taken from the literature were rated for relevance on a scale from 1 to 9, with a median rating of 7 or higher suggesting relevance. The RAND/UCLA method was used to determine consensus. In round 2, indicators lacking consensus were re-rated together with a series of new indicators generated by the experts. Additional details were sought for some indicators. The main outcomes were the relevance of, consensus on, and completeness of the proposed indicators for identifying risks of 30-day medication-related readmission.</p></div><div><h3>Results</h3><p>Thirty-eight experts participated in round 1. Consensus was found for all the indicators, with 25 included and 6 excluded. Thirty-four experts participated in round 2. Consensus was found for all 5 newly suggested indicators, and 4 were included. The expert panel prioritized the following indicators: (1) insufficient communication between different healthcare providers, (2) polypharmacy (≥7 medications), (3) low rates of medication adherence (twice-weekly mistakes or missing administration), (4) complex medication regimens (≥3 doses, ≥2 dosage forms and ≥2 administration routes per day), and (5) multimorbidity (≥3 chronic conditions). The final set comprised 29 indicators.</p></div><div><h3>Conclusions</h3><p>The indicator set developed for flagging potential medication-related readmissions could guide priorities for clinical pharmacy services at hospital discharge, improving patient outcomes and resource use. A validation study of these indicators is planned.</p></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"20 6","pages":"Pages 92-101"},"PeriodicalIF":3.9,"publicationDate":"2024-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1551741124000597/pdfft?md5=e843020a0475113f062a1de4c49ef543&pid=1-s2.0-S1551741124000597-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140023016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Modeling individuals' prescription medicine borrowing behavior","authors":"Miray Arslan ,&nbsp;Havva Başak","doi":"10.1016/j.sapharm.2024.02.011","DOIUrl":"10.1016/j.sapharm.2024.02.011","url":null,"abstract":"<div><h3>Background</h3><p>Medicine-sharing behavior can be divided into two groups: borrowing medicine from someone else and lending medicine to someone else without consulting a doctor or a pharmacist. There are many reasons for the behavior that leads individuals to share their prescription medicines. However, there is a lack in the literature to investigate individuals' medicine-sharing behavior and related antecedents and outcomes of this behavior.</p></div><div><h3>Objective(s)</h3><p>The main objective of this study is to model individuals’ prescription medicine borrowing (PMB) behavior via the structural equation model based on the Theory of Planned Behavior (TPB).</p></div><div><h3>Methods</h3><p>A measurement tool was developed according to TPB. Exploratory factor analysis was conducted to determine subfactors of PBM behavior. In the second step, confirmatory factor analysis (CFA) was conducted to confirm whether there is a relationship between the observed variables and their underlying latent constructs. Finally, a structural equation model was conducted to specify the relationships between latent variables. IBM Statistical Package for Social Sciences (IBM SPSS Software) version 22 and LISREL 8.80 were used for data analysis.</p></div><div><h3>Results</h3><p>Study findings reveal that the participants' attitudes and intentions towards PMB are low, and the rate of exhibiting this behavior is also low<strong>.</strong> In the proposed prescription medicine borrowing behavior model, the positive effect of attitude towards PMB, perceived behavioral control related PMB, and subjective norm about PMB on intention towards PMB were found statistically significant. Intention towards PMB has been found to have a positive statistically significant effect on PMB behavior.</p></div><div><h3>Conclusions</h3><p>Based on the results of this study, it is possible to say that TPB is an appropriate theory for modeling PMB. Thus, this model will shed light on healthcare providers and policy-makers to avoid individuals from the adverse effects of PMB behavior.</p></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"20 6","pages":"Pages 84-91"},"PeriodicalIF":3.9,"publicationDate":"2024-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140050746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Blockchain technology: A potential tool for the management of pharma supply chain","authors":"Wasim Akram ,&nbsp;Ramakant Joshi ,&nbsp;Tanweer Haider ,&nbsp;Pankaj Sharma ,&nbsp;Vinay Jain ,&nbsp;Navneet Garud ,&nbsp;Nitin Singh","doi":"10.1016/j.sapharm.2024.02.014","DOIUrl":"10.1016/j.sapharm.2024.02.014","url":null,"abstract":"<div><h3>Background</h3><p>The pharma supply chain comprises various parties including distributors, manufacturers, raw material suppliers, regulators, pharmacies, hospitals, and patients. Due to the product's complexity and transaction flows, an efficient traceability system is needed in the pharma supply chain to identify the current and all previous product owners. Digitizing the track and trace process significantly improves regulatory oversight and guarantees product quality. A distributed platform for shared data that is immutable, trustworthy, accountable, and transparent in the pharmaceutical supply chain could be built using blockchain-based drug traceability.</p></div><div><h3>Objective</h3><p>This review aims to shed light on blockchain technology's significance and necessity for pharmaceutical supply chain management systems.</p></div><div><h3>Method</h3><p>A comprehensive literature review was performed between January 2017 and September 2023. The search was conducted to elaborate on blockchain technology. <em>Blockchain</em> is a software-based technology that logs and records transactions using a block structure arranged chronologically. Cryptography technology links and secures these blocks on a peer-to-peer network. Blockchain is anticipated to transform the pharmaceutical supply chain by giving all participants access to a single, straightforward system that provides transparency, security, and oversight of the end-to-end delivery of goods.</p></div><div><h3>Result</h3><p>In all, various literature data were included in this review. Using a supply chain powered by blockchain has many benefits. To begin with, it gives a thorough account of the entire procedure from start to finish. A single piece of software can manage the entire supply chain. Additionally, it increases communication between parties with permission. The enhanced security and traceability that blockchain offers is another important benefit. A blockchain system can track, trace, and recall products.</p></div><div><h3>Conclusion</h3><p>Blockchain-based pharmaceutical supply chain management enables the tracking of medicinal drug transactions from raw materials suppliers to end consumers. The pharma blockchain has the potential to enhance the security, integrity, data provenance, and functionality of the supply chain due to its transparency, immutability, and auditability.</p></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"20 6","pages":"Pages 156-164"},"PeriodicalIF":3.9,"publicationDate":"2024-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139997905","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}